Analytical Data
-
基因名
TOR1A
- Application
-
别名
TOR1A;DQ2;Torsin-1A
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O14656
-
表达区间
21-332aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MVEPISLGLA LAGVLTGYIY PRLYCLFAEC CGQKRSLSRE ALQKDLDDNL FGQHLAKKII LNAVFGFINN PKPKKPLTLS LHGWTGTGKN FVSKIIAENI YEGGLNSDYV HLFVATLHFP HASNITLYKD QLQLWIRGNV SACARSIFIF DEMDKMHAGL IDAIKPFLDY YDLVDGVSYQ KAMFIFLSNA GAERITDVAL DFWRSGKQRE DIKLKDIEHA LSVSVFNNKN SGFWHSSLIH RNLIDYFVPF LPLEYKHLKM CIRVEMQSRG YEIDEDIVSR VAEEMTFFPK EERVFSDKGC KTVFTKLDYY YDD
-
分子量
38 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TOR1A, also known as Torsin A, is a protein encoded by the TOR1A gene, which is primarily expressed in the brain and is crucial for normal neural function. Research into TOR1A has gained significant attention due to its association with DYT1 dystonia, a movement disorder characterized by involuntary muscle contractions and abnormal postures. Mutations in the TOR1A gene, particularly the deletion of a glutamic acid residue, are known to cause this hereditary disease, suggesting that the dysfunction of Torsin A plays a critical role in the pathophysiology of dystonia. Studies have indicated that TOR1A is involved in various cellular processes, such as protein homeostasis, cellular stress response, and the regulation of cytoskeletal dynamics. This protein is localized in the endoplasmic reticulum and is believed to participate in nuclear pore complex function and mitochondrial dynamics, which might be disrupted in dystonia patients. Understanding the molecular mechanisms underpinning TOR1A’s function and its role in DYT1 dystonia could pave the way for novel therapeutic strategies. Additionally, exploring the interactions of TOR1A with other cellular components may provide insights into its broader implications in neural development and potential links to other neurological disorders. As such, the ongoing investigation of TOR1A not only contributes to the understanding of dystonia but also highlights the complexities of protein function in the nervous system, with potential ramifications for treatments targeting similar disorders.












